756
Participants
Start Date
November 22, 2024
Primary Completion Date
August 28, 2025
Study Completion Date
August 28, 2025
No treatment given
Participants will continue their normal care and will not get any treatment as part of this study.
Rashid Hospital, Dubai
Dubai Hospital, Dubai
Dr. Sulaiman Al Habib Medical Group- Olaya, Riyadh
Fujairah Hospital, Al Fujairah City
Sheikh Khalifa Hospital Fujairah, Al Fujairah City
Al Qassimi Hospital, Sharjah, Sharjah city
King Khaled University Hospital,King Saud Univ. Med. City, Riyadh
Dallah Hospital_Riyadh, Riyadh
King Faisal Specialist Hospital & Research Centre, Riyadh, Riyadh
SMC, Riyadh, Riyadh
Tawam Hospital (SEHA), Abu Dhabhi
King Fahad Armed Forces, Jeddah, Jeddah
King Faisal Specialist Hospital & Research Centre, Jeddah, Jeddah
Almoosa Specialist Hospital, Al Ahsa
Mediclinic Abu Dhabi, Abu Dhabhi
King Salman North Western Armed Force Hospital (NWAFH), Tabuk
Imperial college, Abu Dhabi, Abu Dhabhi
King Fahad Medical City, Riyadh
Cleveland Clinic Abu Dhabi, Abu Dhabhi
Tadwai hospital, Dubai
Lead Sponsor
Novo Nordisk A/S
INDUSTRY